The technology used in the Bayer Didget, to measure blood glucose, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication. It has also been assessed, in a specific population, according to a non-standard protocol.
|Medaval||★ Recommendation||Recent clinical validation; older protocol|
|Institute of Health Economics (CA)||General use||No evidence provided|
Harrison B, Leazenby C, Halldorsdottir S. Accuracy of the CONTOUR® blood glucose monitoring system. J Diabetes Sci Technol. 2011 Jul 1;5(4):1009-13. doi: 10.1177/193229681100500425. PMID: 21880245. Available from: PMC3192609.
15197:2003 - Pass General population
Klingensmith GJ, Aisenberg J, Kaufman F, Halvorson M, Cruz E, Riordan ME, Varma C, Pardo S, Viggiani MT, Wallace JF, Schachner HC, Bailey T. Evaluation of a combined blood glucose monitoring and gaming system (Didget®) for motivation in children, adolescents, and young adults with type 1 diabetes. Pediatr Diabetes. 2013 Aug;14(5):350-7. Epub: 2011 Jun 23. doi: 10.1111/j.1399-5448.2011.00791.x. PMID: 21699639.
Ad Hoc protocol Children and adolescents (Note: Protocol not stated in abstrtact)